Sanofi's Chew on Auvi-Q Voice-Guided Injector

Aug. 15 (Bloomberg) -- Paul Chew, chief science officer for Sanofi Aventis USA, talks about the company's Auvi-Q injection system for the emergency treatment of life-threatening allergic reactions. Auvi-Q is the first and only compact epinephrine auto-injector with audio and visual cues that guide patients and caregivers through the injection process. Chew speaks with Dominic Chu on Bloomberg Television's "Bottom Line." Mark Crumpton also speaks. (Source: Bloomberg)

EVE: Valkyrie: Oculus Rift's Flagship VR Game
27:48 - Hilmar Pétursson, CCP Games chief executive officer, discusses Oculus Rift's flagship virtual reality game, EVE: Valkyrie, with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • How Sonos Benefits From Apple Music Partnership
  • The Top Three Stocks to Watch in Asia Today
  • Are China's Banks Heading for Disaster?